SEC Form 4 · accession 0001645627-18-000042
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Jul 31, 2018
Accepted (ET)
Aug 3, 2018 · 12:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 31, 2018 | P | 2,000 | $0.0316 | A | 25,297,498 | D | |
| Common Stock | Jul 31, 2018 | P | 2,000 | $0.032 | A | 25,299,498 | D | |
| Common Stock | Jul 31, 2018 | P | 3,000 | $0.032 | A | 25,302,498 | D | |
| Common Stock | Jul 31, 2018 | P | 2,000 | $0.033 | A | 25,304,498 | D | |
| Common Stock | Jul 31, 2018 | P | 3,000 | $0.0322 | A | 25,307,498 | D | |
| Common Stock | Aug 1, 2018 | P | 2,000 | $0.0315 | A | 25,309,498 | D | |
| Common Stock | Aug 1, 2018 | P | 2,000 | $0.0319 | A | 25,311,498 | D | |
| Common Stock | Aug 1, 2018 | P | 2,000 | $0.0319 | A | 25,313,498 | D | |
| Common Stock | Aug 1, 2018 | P | 2,000 | $0.0312 | A | 25,315,498 | D | |
| Common Stock | Aug 1, 2018 | P | 2,000 | $0.0312 | A | 25,317,498 | D | |
| Common Stock | Aug 1, 2018 | P | 2,000 | $0.0312 | A | 25,319,498 | D | |
| Common Stock | Aug 1, 2018 | P | 5,000 | $0.0312 | A | 25,324,498 | D | |
| Common Stock | Aug 1, 2018 | P | 2,000 | $0.0314 | A | 25,326,498 | D | |
| Common Stock | Aug 1, 2018 | P | 2,000 | $0.0314 | A | 25,328,498 | D | |
| Common Stock | Aug 1, 2018 | P | 5,000 | $0.0306 | A | 25,333,498 | D | |
| Common Stock | Aug 1, 2018 | P | 2,000 | $0.0306 | A | 25,335,498 | D | |
| Common Stock | Aug 1, 2018 | P | 2,000 | $0.0306 | A | 25,337,498 | D | |
| Common Stock | Aug 1, 2018 | P | 2,000 | $0.0306 | A | 25,339,498 | D | |
| Common Stock | Aug 1, 2018 | P | 10,000 | $0.0314 | A | 25,349,498 | D |
Table II — derivative securities
No Table II lines on this filing.